Hyperion DeFi, Inc. Common Stock earnings per share and revenue
On Nov 13, 2025, HYPD reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -6.52 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 918.00 thousand, with a --% difference. The market reacted with a +0.80% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -4.71 USD, with revenue projected to reach 459.00 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lexaria Bioscience Corp. Common Stock
Report Date
Jan 13, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.07
Surprise
+47.21%
Anixa Biosciences, Inc.
Report Date
Jan 12, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.09
Surprise
-0.78%
FAQ
What were Hyperion DeFi, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Hyperion DeFi, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Hyperion DeFi, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.8%, changed from $4.97 before the earnings release to $5.01 the day after.
When is Hyperion DeFi, Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 13, 2026.
What are the forecasts for Hyperion DeFi, Inc. Common Stock's next earnings report?
Based on 4
analysts, Hyperion DeFi, Inc. Common Stock is expected to report EPS of -$4.71 and revenue of $459.00K for Q4 2025.